An assembly of electrically-powered, portable devices intended to continuously monitor interstitial fluid glucose concentrations in a patient with diabetes mellitus, using an invasive electrochemical technique. It consists of an electrochemical, percutaneously
| Company | Devices | Share |
|---|---|---|
| Medtronic Minimed, Inc. | 122 | 47% |
| Dexcom, Inc. | 82 | 32% |
| Abbott Diabetes Care Inc | 48 | 19% |
| Medtronic Xomed, Inc. | 6 | 2% |
| Signos, Inc. | 1 | 0% |
Company = labeler of record on GUDID. 5 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| MDS | Sensor, glucose, invasive | 86 |
| MDS | Sensor, Glucose, Invasive | 64 |
| QBJ | Integrated Continuous Glucose Monitoring System, Factory Cal | 58 |
| QLG | Integrated Continuous Glucose Monitoring System, Factory Cal | 57 |
| QOG | Injection Data Capture Device | 55 |
| OZP | Automated insulin dosing device system, single hormonal cont | 36 |
Use these as the dimensions to specify in a tender line.
No closely related category with 50+ devices.
259 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Percutaneous interstitial fluid glucose monitoring system, electrochemical", from 5 companies. The largest labeler is Medtronic Minimed, Inc. with 47% of records.
MDS (Sensor, glucose, invasive), MDS (Sensor, Glucose, Invasive), QBJ (Integrated Continuous Glucose Monitoring System, Factory Cal), QLG (Integrated Continuous Glucose Monitoring System, Factory Cal)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add percutaneous interstitial fluid glucose monitoring system, electrochemical to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.